LEO 90105 Ointment in Japanese Subjects With Psoriasis

NCT01422434 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

676

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: LEO 90105 = calcipotriol + betamethasone dipropionate
DRUG: Dovonex® = calcipotriol
DRUG: Rinderon® - DP = betamethasone dipropionate

Sponsor

LEO Pharma

Collaborators

[object Object]